The report "Enteral Feeding Formulas Market by Product (Polymeric, Monomeric, Disease-Specific Formulas), by Stage (Adults, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home Care) - Global Forecast to 2020", The global enteral feeding formulas market is expected to reach USD 5.95 Billion by 2020. This market was valued at USD 4.13 Billion in 2015 and is expected to grow at a CAGR of 7.6% from 2015 to 2020
Browse 187 tables and 72 figures spread through 225 Pages and in-depth TOC on "Enteral Feeding Formulas Market
Early buyers will receive 10% customization on this report.
Substantial growth was observed in the global enteral feeding formulas market in the last decade, majorly due to rising incidences of chronic diseases and disorders, the rapidly growing geriatric population, increasing healthcare expenditure, growing incidences of preterm births, and increasing demand for homecare.
The enteral feeding formulas market is segmented based on product, stage, application, end user, and region. Based on products, the market is segmented into standard and disease-specific formulas. The standard formulas segment is further segmented into polymeric formulas and monomeric formulas. Disease-specific formulas are further subdivided into diabetic, renal, hepatic, pulmonary, and other formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care. On the basis of stage, the enteral feeding formulas market is segmented into adults and pediatrics. On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. By end user, the enteral feeding formulas market is segmented into hospitals and long-term care facilities. Long-term care facilities are further segmented into homecare agencies & hospices and nursing homes and assisted living facilities.
Talk to Our Research Analysts for More Info@
In 2015, the standard formulas segment accounted for the largest share of the enteral feeding formulas market. This segment is also expected to be the fastest-growing segment in this market during the forecast period of 2015 to 2020. Growth in this segment can be attributed to their extensive use in a majority of enterally fed patients, especially chronically tube-fed patients.
Get The Sample Copy Of This Report:
The enteral feeding formulas market in the Asia-Pacific region is expected to offer significant growth opportunities for market players during the forecast period. Growth in this regional segment is majorly attributed to the presence of a large patient pool for chronic diseases and disorders, growing incidences of preterm births, increasing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, growing middle-class population, and growing population in emerging APAC countries.
The prominent players in the enteral feeding formulas market include Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), and Fresenius Kabi AG (Germany) among others.
Browse Related Reports:
Enteral Feeding Devices Market by Product (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringe), by Stage (Adult, Paediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospital, Ambulatory Care) - Global Forecast to 2019.
Nutraceutical Ingredients Market by Type (Pre & Probiotic, Protein, Mineral, Vitamin, Carotenoid, Fiber, Phytochemical), Application (Food, Dietary Supplement, Animal Nutrition, Personal Care), Health Benefits & by Region - Global Trends & Forecast to 2020.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/pharmaceuticals
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets